The Journal of Infectious Diseases, Vol. 165, No. 6 (Jun., 1992), pp. 1082-1085 (4 pages) The product-limit incidence of Mycobacterium avium-intracellulare complex (MAC) bacteremia in 1006 human ...

The Journal of Infectious Diseases, Vol. 172, No. 4 (Oct., 1995), pp. 1149-1152 (4 pages) Mycobacterium avium complex (MAC) in simian immunodeficiency virus (SIV)-infected macaques is a frequent ...

November 11, 2009 (Philadelphia, Pennsylvania) — A subset of patients with solid organ malignancies and pulmonary Mycobacterium avium–complex (MAC) infections might fare worse if the infection is ...

This section presents medications that are known to potentially lead to 'Mycobacterium avium complex infection' as a side effect. It's important to note that mild side effects are quite common with ...

Patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium avium complex had significantly improved survival if they achieved microbiological cure at the end of treatment, ...

Mycobacterium avium complex (MAC) infection is caused by a group of environmental bacteria called Mycobacterium avium complex. These bacteria live harmlessly in the bodies of people with healthy ...

The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium ...

The CRISPR-based assay works by measuring MAC cell-free DNA (MAC-cfDNA) levels within patient blood samples. The test can yield results in as little as two hours, and the published preliminary ...

DRESHER, PA. (WPVI) -- We need bacteria to digest food and absorb nutrients. However, when a bacteria commonly found in soil and water gets into our lungs, it can cause trouble, in the form of a MAC ...

The FDA established the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) as part of the 21st Century Cures Act that was signed into law in December 2016. The LPAD ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious ...

MAC infection is caused by a related group of bacteria, together referred to as the Mycobacterium avium complex (MAC). These bacteria flourish in, for example, water, soil and the bodies of certain ...